Maryland 2023 2023 Regular Session

Maryland House Bill HB703 Engrossed / Bill

Filed 04/03/2023

                     
 
EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW. 
        [Brackets] indicate matter deleted from existing law. 
         Underlining indicates amendments to bill. 
         Strike out indicates matter stricken from the bill by amendment or deleted from the law by 
amendment. 
          *hb0703*  
  
HOUSE BILL 703 
J1   	3lr1884 
    	CF SB 584 
By: Delegate Kerr Delegates Kerr, Pena–Melnyk, Cullison, Alston, Bagnall, 
Bhandari, Chisholm, Guzzone, Hill, Hutchinson, S. Johnson, Kaiser, Kipke, 
R. Lewis, Lopez, Martinez, M. Morgan, Reilly, Rosenberg, Szeliga, Taveras, 
White, and Woods 
Introduced and read first time: February 6, 2023 
Assigned to: Health and Government Operations 
Committee Report: Favorable with amendments 
House action: Adopted 
Read second time: March 21, 2023 
 
CHAPTER ______ 
 
AN ACT concerning 1 
 
Public Health – Parkinson’s Disease Registry – Established Advisory Committee 2 
and Website 3 
 
FOR the purpose of establishing a Parkinson’s Disease Registry in the Maryland 4 
Department of Health; requiring the Department to collect certain data for the 5 
Registry; authorizing the Department to share certain information in the Registry 6 
with certain entities under certain conditions; providing for the confidentiality of 7 
information collected under this Act; requiring the Department to maintain a record 8 
of individuals granted access to confidential information in the Registry; altering the 9 
duties of the Parkinson’s Disease Registry Advisory Committee; requiring the 10 
Committee to meet on a certain basis beginning on a certain date, rather than with 11 
the frequency established by the Secretary of Health; requiring the Maryland 12 
Department of Health, in collaboration with the State –designated health 13 
information exchange, to establish and maintain a certain website that has certain 14 
information related to Parkinson’s disease; and generally relating to the 15 
establishment of a Parkinson’s Disease Registry Parkinson’s disease. 16 
 
BY repealing and reenacting, without amendments, 17 
 Article – Health – General 18 
Section 18–1202 19 
 Annotated Code of Maryland 20 
 (2019 Replacement Volume and 2022 Supplement)  21  2 	HOUSE BILL 703  
 
 
 
BY repealing and reenacting, with amendments, 1 
 Article – Health – General 2 
Section 18–1201 and 18–1203 3 
 Annotated Code of Maryland 4 
 (2019 Replacement Volume and 2022 Supplement) 5 
 
BY repealing 6 
 Article – Health – General 7 
Section 18–1202 8 
 Annotated Code of Maryland 9 
 (2019 Replacement Volume and 2022 Supplement) 10 
 
BY adding to 11 
 Article – Health – General 12 
Section 18–1202 and 18–1204 through 18–1210 13 
 Annotated Code of Maryland 14 
 (2019 Replacement Volume and 2022 Supplement) 15 
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 16 
That the Laws of Maryland read as follows: 17 
 
Article – Health – General 18 
 
18–1201. 19 
 
 (a) In this subtitle the following words have the meanings indicated. 20 
 
 (b) “Advisory Committee” means the Parkinson’s Disease Registry Advisory 21 
Committee. 22 
 
 (c) (1) “PARKINSONISMS ” MEANS CONDITIONS REL	ATED TO 23 
PARKINSON’S DISEASE THAT CAUSE A COMBINATION OF THE MOVEMENT 24 
ABNORMALITIES SEEN I N PARKINSON’S DISEASE. 25 
 
 (2) “PARKINSONISMS ” INCLUDES MULTIPLE SY STEM ATROPHY , 26 
DEMENTIA WITH LEWY BODIES, CORTICOBASAL DEGENER ATION, AND PROGRESSIVE 27 
SUPRANUCLEAR PALSY . 28 
 
 (D) “Parkinson’s disease” means a chronic and progressive disorder resulting from 29 
deficiency of the neurotransmitter dopamine as the consequence of specific degenerative 30 
changes in the area of the brain called the basal ganglia, characterized by tremors at rest, 31 
slow movements, muscle rigidity, stooped posture, and unsteady or shuffling gait. 32 
 
 (E) “REGISTRY” MEANS THE PARKINSON’S DISEASE REGISTRY. 33 
   	HOUSE BILL 703 	3 
 
 
[18–1202. 1 
 
 There is a Parkinson’s Disease Registry Advisory Committee in the Department.] 2 
 
18–1202. 3 
 
 THERE IS A PARKINSON’S DISEASE REGISTRY IN THE DEPARTMENT . 4 
 
18–1203. 5 
 
 (A) THERE IS A PARKINSON’S DISEASE REGISTRY ADVISORY COMMITTEE 6 
IN THE DEPARTMENT . 7 
 
 [(a)] (B) The Advisory Committee shall: 8 
 
 (1) Assist in the development and implementation of a STATE Parkinson’s 9 
Disease Registry; 10 
 
 (2) Determine what data shall be collected and be stored in a STATE 11 
Parkinson’s Disease Registry and the methods to ensure the privacy and confidentiality of 12 
data collected and stored in the registry; and 13 
 
 (3) Advise the Department on Parkinson’s disease and maintaining a 14 
STATE Parkinson’s Disease Registry; AND 15 
 
 (4) CONSULT WITH ENTITIES THAT MAY BE ABLE TO COLLECT DATA 16 
AND WORK IN PARTNERS HIP WITH THE FEDERAL CENTERS FOR DISEASE CONTROL 17 
AND PREVENTION TO AID THE FEDERAL CENTERS FOR DISEASE CONTROL AND 18 
PREVENTION IN CREATIN G A NATIONAL PARKINSON’S DISEASE REGISTRY. 19 
 
 (B) ENTITIES THAT MAY BE CONSULTED UNDER SUBS ECTION (A)(4) OF THIS 20 
SECTION INCLUDE : 21 
 
 (1) THE STATE–DESIGNATED HEALTH IN FORMATION EXCHANGE ; 22 
 
 (2) NONPROFIT ORGANIZATIO NS; AND 23 
 
 (3) COLLEGES OR UNIVERSIT IES. 24 
 
 [(b)] (C) (1) The Secretary shall appoint individuals to serve on the Advisory 25 
Committee, including: 26 
 
 (i) A neurologist; 27 
 
 (ii) A movement disorder specialist; 28  4 	HOUSE BILL 703  
 
 
 
 (iii) A primary care provider; 1 
 
 (iv) A physician informaticist; 2 
 
 (v) A patient with Parkinson’s disease; 3 
 
 (vi) A public health professional; 4 
 
 (vii) A population health researcher familiar with disease registries; 5 
 
 (viii) A Parkinson’s disease researcher; and 6 
 
 (ix) Any other individuals the Secretary determines are necessary. 7 
 
 (2) The Secretary shall establish: 8 
 
 (i) The duration of term limits for members of the Advisory 9 
Committee; 10 
 
 (ii) The frequency of meetings of the Advisory Committee; 11 
 
 (iii) Rules and procedures for conducting business of the Advisory 12 
Committee; and 13 
 
 (iv) (III) Any other rules necessary for the Advisory Committee to 14 
function effectively. 15 
 
 (D) BEGINNING JULY 1, 2023, THE ADVISORY COMMITTEE SHALL MEET AT 16 
LEAST QUARTERLY .  17 
 
18–1204. 18 
 
 (A) THE DEPARTMENT SHALL COLL ECT DATA FOR THE REGISTRY, 19 
INCLUDING DATA ON THE INC IDENCE OF PARKINSON’S DISEASE IN THE STATE AND 20 
RELATED EPIDEMIOLOGI CAL DATA. 21 
 
 (B) THE ADVISORY COMMITTEE, IN CONSULTATION WITH THE 22 
DEPARTMENT , SHALL: 23 
 
 (1) IDENTIFY CATEGORIES O F DATA TO BE COLLECT ED FOR THE 24 
REGISTRY RELATED TO : 25 
 
 (I) PATIENT DEMOGRAPHICS , INCLUDING GEOGRAPHY ; AND 26 
 
 (II) DIAGNOSES; AND 27   	HOUSE BILL 703 	5 
 
 
 
 (2) PERIODICALLY REVIEW T HE DATA COLLECTED FO R THE 1 
REGISTRY TO ASSESS WH ETHER THE: 2 
 
 (I) DATA INCLUDES SUFFICI ENT INFORMATION TO E NSURE 3 
THERE ARE NO DUPLICA TED PATIENT RECORDS IN THE REGISTRY; AND 4 
 
 (II) CATEGORIES OF DATA CO LLECTED SHOULD BE AL TERED. 5 
 
18–1205. 6 
 
 (A) (1) UNLESS OTHERWISE PROV IDED IN THIS SUBTITL E, ALL 7 
INFORMATION COLLECTE D FOR THE REGISTRY UNDER THIS S UBTITLE SHALL BE 8 
CONFIDENTIAL . 9 
 
 (2) THE DEPARTMENT SHALL IMPLEMENT A CODING S YSTEM THAT 10 
REMOVES ANY PERSONAL LY IDENTIFIABLE INFO RMATION OF AN INDIVI DUAL FROM 11 
COLLECTED DATA . 12 
 
 (B) THE DEPARTMENT , IN CONSULTATION WITH THE ADVISORY 13 
COMMITTEE, SHALL ESTABLISH A SY STEM FOR THE COLLECT ION OF DATA FOR THE 14 
REGISTRY AND DISSEMINATION OF INF ORMATION DETERMINING THE INCIDENCE 15 
AND PREVALENCE OF PARKINSON’S DISEASE AND RELATE D PARKINSONISMS .  16 
 
 (C) (1) THE DEPARTMENT , IN CONSULTATION WITH THE ADVISORY 17 
COMMITTEE, SHALL: 18 
 
 (I) NOTIFY, IN WRITING AND ORALL Y, ALL INDIVIDUALS I N THE 19 
STATE DIAGNOSED WITH PARKINSON’S DISEASE OR RELATED PARKINSONISMS 20 
ABOUT THE CREATION O F THE REGISTRY, DATA COLLECTION ASSO CIATED WITH 21 
THE REGISTRY, AND THE RIGHT TO OPT OUT OF PARTICIPATION IN THE REGISTRY; 22 
AND 23 
 
 (II) PROVIDE AN OPPORTUNIT Y TO OPT OUT OF PARTICIPATION 24 
IN THE REGISTRY. 25 
 
 (2) (I) AN INDIVIDUAL WITH PARKINSON’S DISEASE OR RELATED 26 
PARKINSONISMS MAY OP T OUT OF PARTICIPATI NG IN THE REGISTRY BY 27 
SUBMITTING WRITTEN N OTICE TO THE DEPARTMENT . 28 
 
 (II) IF AN INDIVIDUAL OPTS OUT OF PARTICIPATION IN THE 29 
REGISTRY, THE DEPARTMENT : 30 
  6 	HOUSE BILL 703  
 
 
 1. SHALL RECORD AN INCID ENCE OF A PATIENT WI TH 1 
PARKINSON’S DISEASE; AND 2 
 
 2. MAY NOT RECORD ANY AD DITIONAL INFORMATION 3 
ABOUT THE INDIVIDUAL . 4 
 
 (D) THE DEPARTMENT MAY : 5 
 
 (1) CREATE, REVIEW, AND REVISE A LIST OF DATA POINT S REQUIRED 6 
AS PART OF MANDATED PARKINSON’S DISEASE REPORTING UNDER THIS SECTION , 7 
INCLUDING NECESSARY TRIGGERING DIAGNOSTI C CONDITIONS THAT AR E 8 
CONSISTENT WITH THE LATEST INTERNATIONAL STATISTICAL CLASSIFICATION OF 9 
DISEASES AND RELATED HEALTH PROBLEMS; AND 10 
 
 (2) IMPLEMENT THE COLLECT ION OF DATA POINTS O N THE LIST 11 
CREATED UNDER ITEM (1) OF THIS SUBSECTION T HROUGH A BULLETIN , OR SIMILAR 12 
INSTRUCTION, TO NURSE PRACTITIONE RS, PHYSICIANS, AND PHYSICIAN 13 
ASSISTANTS. 14 
 
 (E) AT LEAST 180 DAYS BEFOR E THE DEPARTMENT ADOPTS MAN DATORY 15 
REPORTING OF PARKINSON’S DISEASE AND RELATE D PARKINSONISMS , THE 16 
DEPARTMENT SHALL PROV IDE NOTIFICATION OF THE MANDATORY REPORT ING OF 17 
PARKINSON’S DISEASE AND RELATE D PARKINSONISMS : 18 
 
 (1) ON THE DEPARTMENT ’S WEBSITE; 19 
 
 (2) DIRECTLY TO ASSOCIATI ONS REPRESENTING HOS PITALS, 20 
HEALTH CARE PROFESSI ONALS, AND OTHER HEALTH CAR E PROVIDERS IN THE 21 
STATE; AND 22 
 
 (3) DIRECTLY TO THE STATE BOARD OF NURSING AND THE STATE 23 
BOARD OF PHYSICIANS. 24 
 
 (F) (1) A NURSE PRACTITIONER , PHYSICIAN, OR PHYSICIAN ASSISTANT 25 
WHO DIAGNOSES PATIEN TS WITH PARKINSON’S DISEASE AND RELATE D 26 
PARKINSONISMS SHALL REPORT EACH CASE OF PARKINSON’S DISEASE AND 27 
RELATED PARKINSONISM S TO THE REGISTRY IN A FORMAT DETERMINED BY THE 28 
DEPARTMENT . 29 
 
 (2) THE DEPARTMENT MAY USE EX ISTING REPORTING PROCED URES 30 
TO IMPLEMENT THE REQ UIREMENT UNDER PARAG RAPH (1) OF THIS SUBSECTION 31 
FOR DIAGNOSIS REPORT ING AND DATA SUBMISS ION BY A NURSE PRACT ITIONER, 32 
PHYSICIAN, OR PHYSICIAN ASSISTA NT.  33 
   	HOUSE BILL 703 	7 
 
 
18–1206. 1 
 
 (A) THE DEPARTMENT MAY ENTER INTO AGREEMENTS TO PROVIDE DATA 2 
COLLECTED IN THE REGISTRY WITH PARKINSON’S DISEASE REGISTRIES IN OTHER 3 
STATES, FEDERAL PARKINSON’S DISEASE CONTROL AG ENCIES, LOCAL HEALTH 4 
DEPARTMENTS , OR HEALTH RESEARCHER S FOR THE STUDY OF PARKINSON’S 5 
DISEASE AND RELATED PARKINSONISMS . 6 
 
 (B) (1) BEFORE CONFIDENTIAL I NFORMATION IS DISCLO SED UNDER 7 
SUBSECTION (A) OF THIS SECTION , THE DEPARTMENT SHALL RECE IVE A WRITTEN 8 
AGREEMENT FROM THE P ARTNERING ENTITY TO MAINTAIN THE CONFIDE NTIALITY 9 
OF THE INFORMATION . 10 
 
 (2) IF THE ENTITY RECEIVI NG CONFIDE NTIAL DATA FROM THE 11 
REGISTRY IS A RESEARC H ENTITY, THE RESEARCH ENTITY SHALL: 12 
 
 (I) OBTAIN APPROVAL FROM THE COMMITTEE AT THE 13 
RESEARCH ENTITY THAT NORMALLY REVIEWS RES EARCH PROJECTS FOR T HE 14 
PROTECTION OF HUMAN SUBJECTS ESTABLISHED IN ACCORDANCE WITH TITLE 45 15 
OF THE CODE OF FEDERAL REGULATIONS; AND 16 
 
 (II) PROVIDE DOCUMENTATION TO THE DEPARTMENT THAT 17 
DEMONSTRATES , TO THE DEPARTMENT ’S SATISFACTION , THAT THE RESEARCH 18 
ENTITY HAS ESTABLISH ED PROCEDURES AND TH E ABILITY TO MAINTAI N THE 19 
CONFIDENTIALITY OF T HE DISCLOSED INFORMAT ION. 20 
 
 (C) THE DEPARTMENT SHALL ESTA BLISH PROCEDURES TO REVIEW AND 21 
APPROVE REQUESTS TO USE REGISTRY DATA FOR SCI ENTIFIC RESEARCH . 22 
 
18–1207. 23 
 
 (A) NOTWITHSTANDING ANY O THER PROVISION OF LA W OR RULE OF 24 
PROCEDURE OR EVIDENC E IN THE MARYLAND RULES: 25 
 
 (1) A DATA DISCLOSURE AUTH ORIZED BY THIS SUBTI TLE MAY NOT: 26 
 
 (I) INCLUDE INFORMATION O THER THAN THE INFORM ATION 27 
NECESSARY FOR THE PU RPOSE OF THE DISCLOS URE; 28 
 
 (II) BE USED FOR A PURPOSE OTHER THAN THE PURPO SE FOR 29 
THE DISCLOSURE ; OR 30 
 
 (III) BE FURTHER DISCLOSED ; 31 
  8 	HOUSE BILL 703  
 
 
 (2) THE CONFIDENTIAL INFO RMATION COLLECTED FO R THE 1 
REGISTRY MAY NOT BE M	ADE AVAILABLE FOR SU BPOENA, DISCLOSED, 2 
DISCOVERABLE , OR COMPELLED TO BE P RODUCED IN ANY CIVIL , CRIMINAL, 3 
ADMINISTRATIVE , OR OTHER PROCEEDING ; AND 4 
 
 (3) THE CONFIDENTIAL INFO RMATION COLLECTED FO R THE 5 
REGISTRY MAY NOT BE D EEMED ADMISSIBLE AS EVIDENCE IN ANY CIVI L, CRIMINAL, 6 
ADMINISTRATIVE , TRIBUNAL, OR OTHER PROCEEDING . 7 
 
 (B) (1) THIS SECTION DOES NOT PREEMPT THE AUTHORIT Y OF A HEALTH 8 
CARE PROVIDER , AS DEFINED IN § 19–132 OF THIS ARTICLE , PROVIDING 9 
DIAGNOSTIC SERVICES OR TREATMENT TO PATI ENTS WITH PARKINSON’S DISEASE 10 
OR RELATED PARKINSON ISMS TO MAINTAIN A PARKINSON’S DISEASE REGISTRY . 11 
 
 (2) THIS SECTION DOES NOT PROHIBIT THE PUBLICA TION OF 12 
REPORTS AND S TATISTICAL COMPILATI ONS THAT DO NOT IDEN TIFY INDIVIDUALS 13 
WITH PARKINSON’S DISEASE OR RELATED PARKINSONISMS OR IND IVIDUAL 14 
SOURCES OF INFORMATI ON.  15 
 
18–1208. 16 
 
 (A) THE DEPARTMENT SHALL MAIN TAIN A RECORD OF IND IVIDUALS 17 
GRANTED ACCESS TO CO NFIDENTIAL INFORMATION FROM THE REGISTRY. 18 
 
 (B) THE DEPARTMENT MAY NOT DE NY A REQUEST FOR INS PECTION OF THE 19 
RECORD MAINTAINED UN DER SUBSECTION (A) OF THIS SECTION UNDE R TITLE 4 OF 20 
THE GENERAL PROVISIONS ARTICLE. 21 
 
 (C) THE RECORD MAINTAINED UNDER SUBSECTION (A) OF THIS SECTION 22 
SHALL INCLUDE THE AC CESSING INDIVIDUAL ’S:  23 
 
 (1) NAME; 24 
 
 (2) TITLE; 25 
 
 (3) ADDRESS; 26 
 
 (4) ORGANIZATIONAL AFFILI ATION; 27 
 
 (5) DATES OF ACCESS; AND 28 
 
 (6) PURPOSE FOR ACCESSING THE INFORMATION . 29 
 
18–1209. 30   	HOUSE BILL 703 	9 
 
 
 
 THE DEPARTMENT SHALL ADOP T REGULATIONS NECESSARY TO CARRY O UT 1 
THIS SUBTITLE. 2 
 
18–1210. 3 
 
 (A) ON OR BEFORE DECEMBER 1 EACH YEAR, BEGINNING IN 2023, THE 4 
ADVISORY COMMITTEE SHALL REPOR T TO THE SECRETARY OF HEALTH AND, IN 5 
ACCORDANCE WITH § 2–1257 OF THE STATE GOVERNMENT ARTICLE, THE SENATE 6 
FINANCE COMMITTEE AND THE HOUSE HEALTH AND GOVERNMENT OPERATIONS 7 
COMMITTEE ON THE REGISTRY AND THE PREV ALENCE OF PARKINSON’S DISEASE IN 8 
THE STATE. 9 
 
 (B) THE DEPARTMENT SHALL POST THE REPORT REQUIRED UNDER 10 
SUBSECTION (A) OF THIS SECTION ON A DEDICATED WEBSITE ACCESSIBLE TO THE 11 
PUBLIC. 12 
 
18–1204. 13 
 
 (A) THE DEPARTMENT , IN COLLABORATION WIT H THE STATE–DESIGNATED 14 
HEALTH INFORMATION E XCHANGE, SHALL ESTABLISH AND MAINTAIN A PUBLICLY 15 
ACCESSIBLE WEBSITE T HAT HAS THE FOLLOWIN G INFORMATION IN A 16 
DOWNLOADABLE FORMAT : 17 
 
 (1) THE INCIDENCE OF PARKINSON’S DISEASE IN THE STATE; AND  18 
 
 (2) TO THE EXTENT POSSIBL E, THE INCIDENCE OF PARKINSON’S 19 
DISEASE DISAGGREGATE D BASED ON: 20 
 
 (I) AGE, INCLUDING AGE OF DIA GNOSIS; 21 
 
 (II) GENDER; 22 
 
 (III) SEX; 23 
 
 (IV) RACE;  24 
 
 (V) ETHNICITY; AND 25 
 
 (VI) CASES BY COUNTY . 26 
 
 (B) THE WEBSITE REQUIRED UNDER SUBSECTION (A) OF THIS SECTION 27 
SHALL: 28 
  10 	HOUSE BILL 703  
 
 
 (1) INCLUDE THE DATA AVAI LABLE FOR THE 5–YEAR PERIOD ENDING 1 
ON SEPTEMBER 30, 2023; AND 2 
 
 (2) BE UPDATED ON OR BEFO RE JANUARY 1 EACH YEAR, TO INCLUDE 3 
ANY NEWLY AVAILABLE DATA. 4 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That on or before July 1, 2024, the 5 
Parkinson’s Disease Registry Advisory Committee shall report to the Senate Finance 6 
Committee and the House Health and Government Operations Committee, in accordance 7 
with § 2–1257 of the State Government Article, on recommendations for a path forward 8 
toward the establishment of a fully functional State Parkinson’s Disease Registry. 9 
 
 SECTION 3. AND BE IT FURTHER ENACTED, That the Maryland Department of 10 
Health shall establish the website required under § 18–1204 of the Health – General 11 
Article, as enacted by Section 1 of this Act, on or before October 1, 2023.  12 
 
 SECTION 2. 4. AND BE IT FURTHER ENACTED, That this Act shall take effect 13 
October June 1, 2023. 14 
 
 
 
 
Approved: 
________________________________________________________________________________  
 Governor. 
________________________________________________________________________________  
  Speaker of the House of Delegates. 
________________________________________________________________________________  
         President of the Senate.